Position
Pfizer Inc in Celcuity Inc.
Back to the book · All holders of CELC
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $1.86M$99.74 → $106.02
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 349.4K | $34.8M | — | — | — | 14.7% |
| Q1 2026 | 295.7K | $31.3M | $106.02 | $1.86M | −$5.36M | 13.1% |